Learn / ARQT
NASDAQ: ARQT
Arcutis Biotherapeutics (ARQT) stock, explained like you're 5
Arcutis Biotherapeutics trades on the Nasdaq under the ticker ARQT. It is a mid cap company in the pharmaceutical preparations industry, part of the healthcare sector, with a market value of about 3.3 billion dollars.
- Ticker
- ARQT
- Exchange
- Nasdaq
- Sector
- Healthcare
- Industry
- Pharmaceutical Preparations
- Size
- Mid cap, about 3.3 billion dollars
Is Arcutis Biotherapeutics a small, medium or large cap company?
No. Arcutis Biotherapeutics is a mid cap stock, not a large cap. Its market cap, which is the total value of all its shares, is about 3.3 billion dollars.
Here is how you can tell. Multiply the share price by the number of shares to get the market cap, then compare it to the usual sizes. Micro cap is under 300 million dollars, small cap is 300 million to 2 billion, mid cap is 2 to 10 billion, large cap is 10 billion and up, and mega cap is over 200 billion. Market caps move every day with the share price, so treat the number as a recent snapshot.
How Arcutis Biotherapeutics makes money
- Selling medicines, medical devices or healthcare services.
- Insurance premiums or hospital and clinic fees.
- Research and licensing deals.
What moves ARQT stock
- Results from clinical trials and approvals from regulators.
- Drug prices, insurance rules and government policy.
- Patents running out and new competing treatments.
In the news lately
- Arcutis Biotherapeutics (ARQT) Unveiled Fresh ZORYVE Data, Is The Stock Still Below Fair Value? (Simply Wall Street)
- Arcutis Biotherapeutics, Inc. (ARQT) Stock Forecasts (Yahoo Finance)
- Why Is Arcutis Biotherapeutics Stock Surging Thursday? (Benzinga)
- Arcutis stock wins new Overweight at Cantor (ARQT:NASDAQ) (Seeking Alpha)
- (ARQT) Movement as an Input in Quant Signal Sets (Stock Traders Daily)
Follow ARQT in your daily brief
Each trading day at 5 PM ET we post what happened to Arcutis Biotherapeutics and why it matters, in simple words. Free.
Start my free briefKey terms to know before you follow ARQT
Questions about Arcutis Biotherapeutics stock
What does Arcutis Biotherapeutics do?
Arcutis Biotherapeutics trades on the Nasdaq under the ticker ARQT. It is a mid cap company in the pharmaceutical preparations industry, part of the healthcare sector, with a market value of about 3.3 billion dollars.
What is the ticker symbol for Arcutis Biotherapeutics?
Arcutis Biotherapeutics trades under the ticker ARQT on the Nasdaq.
What is Arcutis Biotherapeutics's market cap?
Arcutis Biotherapeutics is a mid cap stock with a market cap of about 3.3 billion dollars.
How does Arcutis Biotherapeutics make money?
Selling medicines, medical devices or healthcare services. Insurance premiums or hospital and clinic fees. Research and licensing deals.
What moves ARQT stock?
Results from clinical trials and approvals from regulators. Drug prices, insurance rules and government policy. Patents running out and new competing treatments.
How can I follow ARQT stock every day?
Add ARQT to your watchlist on Metric Finance. We post a free brief every trading day at 5 PM ET that explains what happened to the stocks you follow, in simple words.
Similar stocks
Educational information, not financial advice. This guide explains the business in general terms and does not include live prices.